HAL (France)open access
Real‐Life Effectiveness After Switching to Avalglucosidase Alfa in Late‐Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study
1, Treatment management, Switch, Glycogenosis, Enzymotherapy, 0, Unmet needs
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 471871
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.